Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurore M M Dupuy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Methods in Cell Biology|March 26, 2023
Using mammary organoids to study ciliaAurore M M Dupuy, Philippe P Juin, Vincent J Guen
Genesis (New York, N.Y. : 2000)|November 10, 2023
EMT and primary ciliogenesis: For better or worse in sickness and in healthCamille E Tessier, Aurore M M Dupuy, Thomas Pelé, et al.
Biology of the Cell|November 9, 2024
CRCI<sup>2</sup>NA inaugural symposium: A meeting on tumor and immune ecosystemsVincent J Guen, Gwennan André-Grégoire, Céline Beauvillain, et al.
EMBO Molecular Medicine|August 26, 2025
EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancerCamille E Tessier, Jennifer Derrien, Aurore M M Dupuy, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Methods in Cell Biology|March 26, 2023
Using mammary organoids to study ciliaAurore M M Dupuy, Philippe P Juin, Vincent J Guen
Genesis (New York, N.Y. : 2000)|November 10, 2023
EMT and primary ciliogenesis: For better or worse in sickness and in healthCamille E Tessier, Aurore M M Dupuy, Thomas Pelé, et al.
Biology of the Cell|November 9, 2024
CRCI<sup>2</sup>NA inaugural symposium: A meeting on tumor and immune ecosystemsVincent J Guen, Gwennan André-Grégoire, Céline Beauvillain, et al.
EMBO Molecular Medicine|August 26, 2025
EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancerCamille E Tessier, Jennifer Derrien, Aurore M M Dupuy, et al.
Pageof 1